Pär‐Ola Bendahl

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Gabriella Honeth, Pär‐Ola Bendahl, Markus Ringnér et al. · Breast Cancer Research · 2008 · 554 citations · Full text

Medicine, Cell Biology, Oncology +17

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Lao H. Saal, Peter A. Johansson, Karolina Holm et al. · Proceedings of the National Academy of Sciences · 2007 · 521 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Eleonor Olsson, Christof Winter, Anthony M. George et al. · EMBO Molecular Medicine · 2015 · 452 citations · Full text

Medicine, Oncology, Pathology +17

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

Olöf Bjarnadottir, Quinci Romero, Pär‐Ola Bendahl et al. · Breast Cancer Research and Treatment · 2013 · 236 citations

Medicine, Oncology, Pharmacology +8